KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Thermo Fisher Scientific (TMO) Enterprise Value (2016 - 2025)

Thermo Fisher Scientific (TMO) has disclosed Enterprise Value for 16 consecutive years, with -$6.5 billion as the latest value for Q3 2024.

  • For the quarter ending Q3 2024, Enterprise Value fell 8.04% year-over-year to -$6.5 billion, compared with a TTM value of -$6.5 billion through Sep 2024, down 8.04%, and an annual FY2023 reading of -$8.0 billion, up 5.3% over the prior year.
  • Enterprise Value was -$6.5 billion for Q3 2024 at Thermo Fisher Scientific, up from -$8.7 billion in the prior quarter.
  • Across five years, Enterprise Value topped out at -$1.8 billion in Q3 2022 and bottomed at -$12.0 billion in Q4 2021.
  • Average Enterprise Value over 5 years is -$6.0 billion, with a median of -$6.0 billion recorded in 2023.
  • The sharpest move saw Enterprise Value tumbled 492.3% in 2020, then skyrocketed 76.72% in 2022.
  • Year by year, Enterprise Value stood at -$10.3 billion in 2020, then surged by 57.82% to -$4.4 billion in 2021, then crashed by 93.07% to -$8.4 billion in 2022, then rose by 5.3% to -$8.0 billion in 2023, then rose by 18.14% to -$6.5 billion in 2024.
  • Business Quant data shows Enterprise Value for TMO at -$6.5 billion in Q3 2024, -$8.7 billion in Q2 2024, and -$7.1 billion in Q1 2024.